Bluejay Diagnostics, Inc. (BJDX) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $5.98M | +4.3% |
| 2024 | $5.73M | +97.9% |
| 2023 | $2.89M | -74.9% |
| 2022 | $11.54M | -43.4% |
| 2021 | $20.38M | +584.6% |
| 2020 | -$4.21M | -43.4% |
| 2019 | -$2.93M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $5.98M | +4.3% |
| 2024 | $5.73M | +97.9% |
| 2023 | $2.89M | -74.9% |
| 2022 | $11.54M | -43.4% |
| 2021 | $20.38M | +584.6% |
| 2020 | -$4.21M | -43.4% |
| 2019 | -$2.93M | — |